Table 4 Paired comparison of RDS weights for three key study outcomes
Crude | RDS-I | RDS-II | RDS-SS | RDS-II – RDS-I | RDS-SS – RDS-I | RDS-SS – RDS-II | |
|---|---|---|---|---|---|---|---|
HIV-positive serostatus | |||||||
Mean % (95% CI) | 27.0 (12.3–39.3) | 22.2 (10.3–31.9) | 25.7 (10.7–36.3) | 25.7 (10.7–36.3) | 3.4 (−0.9–7.5) | 3.4 (−0.9–7.5) | 0.0 (−) |
p-value | 0.11 | 0.11 | 0.22 | ||||
Any high risk sex in past 6 months | |||||||
Mean % (95% CI) | 37.0 (32.2–41.9) | 34.3 (26.7–41.4) | 33.1 (25.3–39.4) | 33.1 (25.3–39.4) | −1.2 (−2.9–0.3) | −1.2 (−2.9–0.3) | 0.0 (0.0–0.1) |
p-value | 0.12 | 0.12 | 0.28 | ||||
Injected any drugs in past 6 months | |||||||
Mean % (95% CI) | 6.6 (2.6–11.3) | 9.0 (2.3–14.0) | 6.7 (1.8–11.7) | 6.7 (1.8–11.6) | −2.3 (−3.0–0.0) | −2.3 (−3.0–0.0) | 0.0 (−) |
p-value | 0.06 | 0.06 | 0.18 | ||||